Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Michael Sendker

1PUBLICATIONS
3CO-AUTHORS
Medical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 15, 2023
RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.

Stephanie Sendker, Amani Awada, Sophia Domagalla

Pageof 1

Frequent Collaborators

1 joint publications

Stephanie Sendker

1 joint publications

Naghmeh Niktoreh

1 joint publications

Dirk Reinhardt

Frequent Collaborators

1 joint publications

Stephanie Sendker

1 joint publications

Naghmeh Niktoreh

1 joint publications

Dirk Reinhardt

Top Related Videos

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on : Sep 01, 2019

7.6K
See more related videos

Top Related Videos

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on : Sep 01, 2019

7.6K
See more related videos